XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 22 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,981,000 | – | 2,000,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,240,000 | $6,256,000 | 1.36% |
| Context Partners Fund, L.P. | 3,240,000 | $6,256,000 | 1.36% |
| Sessa Capital IM, L.P. | 7,450,000 | $14,444,000 | 1.18% |
| 683 Capital Management, LLC | 7,500,000 | $14,550,000 | 1.07% |
| SILVERBACK ASSET MANAGEMENT LLC | 2,500,000 | $4,850,000 | 1.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,000,000 | $36,116,000 | 0.88% |
| CAMDEN ASSET MANAGEMENT L P /CA | 14,000,000 | $27,032,000 | 0.86% |
| Soros Fund Management | 6,986,000 | $13,597,000 | 0.33% |
| Hudson Bay Capital Management LP | 8,200,000 | $16,003,000 | 0.24% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,000,000 | $3,861,000,000 | 0.10% |